# Fridays reviews (2026): GLP-1 telehealth sellers | This GLP The pricing page and the treatment page give different annual rates for the same plan, and the discount figure needs a coupon. Publisher: This GLP Editorial Team Canonical: https://thisglp.com/reviews/fridays Updated: 2026-10-28 By [This GLP Editorial Team](https://thisglp.com/about) · Updated September 2026 Two pages, two answers # Fridays review The pricing page and the treatment page give different annual rates for the same plan, and the discount figure needs a coupon. ## The verdict Fridays publishes $249 a month for compounded semaglutide and $359 for tirzepatide on a month-to-month plan, alongside an annual rate that two of its own pages state differently. **Disclosure:** This GLP is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. The order on this page is not commercial, and a commission never changes what we write about a provider. [How we make money](https://thisglp.com/disclosures). Category GLP-1 telehealth Molecule Semaglutide · Tirzepatide Form Injection From From $249/mo Prescription Required Compounded Yes — not FDA-approved Fridays sells both molecules by injection on month-to-month and annual plans, and the figures a reader meets depend on which of two pages they land on first. 1. ## Who writes the prescription, and what do they see? A prescription is issued before shipping and neither page describes the clinician who writes it, which is a smaller gap than it would normally be, because the pages cannot yet agree on what the treatment costs. One page puts the annual plan at $150 a month and another at $279, and a reader has no way to tell which is current. That is not a hidden fee or a clever framing — it is the same company publishing two answers to one question, and a buyer who plans around the lower one has been misled by a page the seller wrote itself. 2. ## What happens when the dose goes up? Nothing is published about what either figure does at a higher dose. On a plan whose headline rate is already in dispute across two pages, a reader should treat the dose question as unanswered rather than assume the rate holds. 3. ## What the price includes The month-to-month rates are the only figures both pages agree on: $249 for semaglutide and $359 for tirzepatide. The annual rate is either $150 or $279 depending on the page, a $129 spread. And the two discount figures, $117 and $198, are gated behind promo codes rather than standing rates, so neither is available to a reader who simply signs up. Get the applicable annual rate confirmed in writing before paying anything. 4. ## What it claims, and what it cites Both lines are compounded rather than manufactured, prepared by a pharmacy the site does not name, and not reviewed by the FDA before dispensing as an approved product is. ## Where it holds up, and where it does not - Strength: Month-to-month rates agree across pages - Strength: Both molecules carry published figures - Strength: The promo codes are shown, not hidden - Limitation: Two pages give different annual rates - Limitation: The lowest figures need a promo code - Limitation: Nothing published about dose pricing - Limitation: No state coverage list is recorded ## What the evidence says about this kind of treatment The assessment above is about Fridays. These are about the drugs it sells, and they are traced to the primary literature. - [What happens to the dose, and to the side effects, over the first twenty weeks?](https://thisglp.com/research/how-long-does-nausea-last-on-a-glp1) - [How much of the weight lost is muscle, and what changes that?](https://thisglp.com/research/muscle-loss-on-glp1) - [What does the trial evidence show when treatment stops?](https://thisglp.com/research/stopping-glp1-and-weight-regain) Right for A reader who will get the annual rate confirmed in writing before paying. Wrong for A reader planning a year from whichever page they happened to open. ## The evidence behind what Fridays prescribes These studies examine the medicines, not this provider. Results with approved products do not establish the quality or effectiveness of a seller’s compounded formulation. - [Cochrane Review of Semaglutide for Obesity: 18 Trials Graded](https://thisglp.com/research/semaglutide-cochrane-review) A 2025 Cochrane review pooled eighteen randomized trials. The weight figure is high certainty and smaller than the marketing, and almost everything else is graded lower. - [Tirzepatide vs Semaglutide: Which Works Better for Weight Loss?](https://thisglp.com/research/tirzepatide-vs-semaglutide-which-works-better) In a 72-week randomized trial at weight-management doses, weight fell 20.2 percent on tirzepatide and 13.7 percent on semaglutide. Routine-care studies found a smaller gap, three to four points. ## How Fridays compares | Seller | Who it suits | Go | | --- | --- | --- | | Genesis Health | Readers who want the billed amount, not just the monthly rate, before committing | | | Get Thin MD | Readers taking the three-month plan who read what the sale actually covers | | | Harmony Wellness Clinic | Readers who want to cost out a full escalation before starting one | | [Compare all providers side by side →](https://thisglp.com/best) More GLP-1 telehealth sellers reviews: [TrimRx](https://thisglp.com/reviews/trimrx) [Trinity Meds](https://thisglp.com/reviews/trinity-meds) [TRT Nation](https://thisglp.com/reviews/trt-nation) [Tru2u](https://thisglp.com/reviews/tru2u) [TrueMe](https://thisglp.com/reviews/trueme) [Try Ageless](https://thisglp.com/reviews/try-ageless) Sponsored alternative SkinnyRx Readers choosing tirzepatide, the one line with a published standing rate ## Frequently asked What does the annual plan cost? Fridays gives two answers. Its treatment page states $150 a month and its pricing page states $279, and nothing on either explains the difference. Can I get the $117 rate? Only with a promo code. The advertised $117 and $198 figures are coupon-gated rather than standing rates. What is the month-to-month price? $249 for semaglutide and $359 for tirzepatide, which is the one figure both pages agree on. Is Fridays expensive compared with other GLP-1 telehealth sellers? Fridays publishes a starting figure of $249/mo. Across the 402 GLP-1 telehealth sellers we review that publish a single monthly figure, those run $49 to $525.42 with a median of $190, which puts Fridays above the median. The other 178 GLP-1 telehealth sellers we review quote only after an intake or price by dose, so they are not in that comparison. A starting figure is not a bill — labs, consultations and shipping are often charged separately, so confirm what your own quote includes. Or [compare every seller we cover](https://thisglp.com/best). **Research, not medical advice.** This GLP is independent and educational. Nothing here is a substitute for individualized care from a licensed clinician, and reading it creates no doctor–patient relationship. Talk to your own provider before starting, stopping, or changing any medication, peptide, or therapy. See our [methodology](https://thisglp.com/methodology) and [terms](https://thisglp.com/terms).